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r2 = 0.065; p = 0.004) shows a weak relationship between 
SjO2 and SctO2.
Conclusions Sevoflurane maintains higher SjO2 levels than 
propofol during RALP. SctO2 does not accurately reflect 
SjO2.
Keywords Robotic-assisted laparoscopic prostatectomy 
(RALP) · Steep Trendelenburg position · Cerebral 
oxygenation · Sevoflurane · Propofol
Introduction
Robotic-assisted laparoscopic prostatectomy (RALP) 
requires a steep Trendelenburg position and pneumoperi-
toneum, both of which can increase intracranial pressure 
(ICP) [1, 2]. Increased ICP, in turn, may decrease cerebral 
perfusion pressure and cerebral oxygenation [3, 4].
Although sevoflurane and propofol are commonly used 
anesthetics, they have different effects on cerebral blood 
flow (CBF) and the cerebral metabolic rate for oxygen 
(CMRO2). Volatile anesthetics primarily increase CBF via 
local vasodilatation and reduce CMRO2. At low concentra-
tions, where the effect of CMRO2 is dominant, these anes-
thetics constrict cerebral vessels by suppressing CMRO2 
and prevent an increase in the CBF and CBF/CMRO2 ratio. 
At the medium-to-high concentrations commonly used in 
clinical settings, the direct vasodilatory effect becomes 
dominant, causing CBF and the CBF/CMRO2 ratio to 
increase. With sevoflurane, this effect is accompanied by an 
increase in cerebral blood volume (CBV) and an elevated 
ICP [5]. In RALP, where ICP is already increased, it is con-
ceivable that the CBV increase caused by volatile anesthet-
ics could further increase ICP and in turn lower the CBF/
CMRO2 ratio and cerebral oxygenation. Supporting this 
Abstract 
Purpose Steep Trendelenburg position and pneumoperito-
neum during robotic-assisted laparoscopic prostatectomy 
(RALP) increase intracranial pressure (ICP) and may alter 
cerebral blood flow (CBF) and oxygenation. Volatile anes-
thetics and propofol have different effects on ICP, CBF, and 
cerebral metabolic rate and may have different impact on 
cerebral oxygenation during RALP. In this study, we meas-
ured jugular venous bulb oxygenation (SjO2) and regional 
oxygen saturation (SctO2) in patients undergoing RALP to 
evaluate cerebral oxygenation and compared the effects of 
sevoflurane and propofol. We also verified whether SctO2 
may be an alternative to SjO2.
Methods Fifty patients scheduled for RALP were ran-
domly assigned to undergo sevoflurane (group S) or propo-
fol (group P) anesthesia. SjO2, SctO2, mean arterial pres-
sure (MAP), heart rate (HR), cardiac index (CI), central 
venous pressure (CVP), partial pressures of arterial oxygen 
(PaO2) and carbon dioxide (PaCO2), hemoglobin concen-
tration (Hb), Bispectral Index (BIS) and nasopharyngeal 
temperature (BT) were recorded 5 min before surgery com-
mencement, 5 min after pneumoperitoneum, 5, 30, 60, 90, 
and 120 min after pneumoperitoneum in a Trendelenburg 
position, and after desufflation in a supine position.
Results SjO2 was significantly higher in group S than in 
group P at all measurement points [group S vs. group P: 
77 % (11) vs. 65 % (13), mean of all measurement points 
(1SD); p < 0.01]. Linear regression analysis (β = 0.106; 
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hypothesis, one study showed cerebral oxygen desatura-
tion in a steep Trendelenburg position and pneumoperito-
neum with isoflurane anesthesia [4]. Propofol reduces CBF 
by cerebral vasoconstriction and suppresses CMRO2. The 
relationship between the vasoconstriction and CMRO2 sup-
pression effects of propofol is unclear; some studies have 
reported approximate equivalency [6], and others have 
reported that vasoconstriction is slightly dominant [7]. 
Propofol at least does not increase the CBF/CMRO2 ratio. 
Volatile anesthetics and propofol each have the potential to 
decrease cerebral oxygenation during RALP.
Patients undergoing RALP are typically elderly and 
often have cerebrovascular disease that is associated with 
impaired cerebral oxygenation. These are not only asso-
ciated with cerebral vasoconstriction or vasospasm dur-
ing surgery but also with postoperative cognitive decline 
(POCD) [8]. Some studies suggest that the choice of anes-
thetic affects cerebral oxygenation and POCD [9, 10]. 
Thus, it is important to monitor cerebral oxygenation and 
choose anesthetics that best preserve cerebral oxygenation.
Jugular venous bulb oxygen saturation (SjO2) accurately 
reflects the CBF/CMRO2 ratio but is invasive and complex 
[11]. By contrast, near-infrared spectroscopy (NIRS) can 
non-invasively assess SctO2, which can reflect the CBF/
CMRO2 ratio [12]. However, it has also been suggested that 
SctO2 and SjO2 are poorly correlated [12, 13].
To date, the difference in SjO2 between common anes-
thetic agents has not been investigated during RALP. In this 
study, we compared the effects of sevoflurane and propofol 
on SjO2, and verified whether SctO2 could be used as an 
alternative to SjO2 during RALP.
Methods
The institutional ethics committee of Iwate Medical Uni-
versity Hospital, Japan, approved this study, and it has 
been registered in the UMIN Clinical Trials Registry 
(UMIN000016685). After obtaining written informed con-
sent, we enrolled adult male patients who were undergo-
ing RALP with the requirement that they were American 
Society of Anesthesiologists physical status class 1 or 2. 
Patients with known histories of cerebral ischemia or hem-
orrhage were excluded. Participants were randomized by 
computer generation into groups that received either sevo-
flurane (group S) or propofol (group P).
Anesthesia was induced in group S by a bolus injec-
tion of thiopental (5 mg/kg) and in group P by an effect-
site target-controlled infusion (TCI) of propofol of 5 µg/
ml; remifentanil (0.2–0.4 µg/kg/min) was used in both 
groups. After administering rocuronium (0.8 mg/kg), the 
trachea was intubated and the lungs were mechanically 
ventilated in volume control mode (tidal volume 8–10 ml/
kg) with an oxygen fraction (FiO2) of 0.45. The respira-
tory rate was adjusted to maintain an end-tidal carbon diox-
ide tension (ETCO2) of 35–40 mmHg. In both groups, the 
concentrations of sedative drugs were adjusted to achieve 
a Bispectral Index (BIS) of 40–60. Sevoflurane was initi-
ated at concentrations of 2.0 % and adjusted above 1.7 % 
(one minimum alveolar concentration; MAC), and propo-
fol was maintained by TCI. Also, remifentanil was adjusted 
to maintain a mean arterial pressure (MAP) within 20 % 
of the preinduction value in both groups. When the MAP 
decreased to 80 % of the preinduction value, it was treated 
with an 8-mg bolus of ephedrine. Patients not anesthe-
tized under these conditions were excluded from the final 
analysis.
Routine monitoring including electrocardiography, 
pulse oximetry, and non-invasive automated blood pres-
sure measurement, started on arrival in the operating room. 
After the induction of anesthesia, a radial artery catheter 
was inserted for direct arterial blood pressure measurement 
and blood sampling. The arterial line was also connected 
to a FloTrac sensor and a third-generation Vigileo moni-
toring system (Edwards Lifesciences, Irvine, CA, USA) to 
monitor the cardiac index (CI) data. The ETCO2 and end-
tidal concentration of sevoflurane were measured using 
a Vamos anesthetic gas monitor (Dräger Japan, Tokyo, 
Japan). Central venous pressure (CVP) was measured by a 
single-lumen central venous catheter that was inserted into 
the right internal jugular vein. A BIS electrode was applied 
to the forehead and was measured continuously using an 
Aspect BIS A2000 monitor v3.31 (Aspect Medical Sys-
tems, Natick, MA, USA). Nasopharyngeal temperature 
(BT) was monitored continuously.
For SctO2 measurement, the cerebral oximeter probes 
were placed bilaterally ≥1 cm above each eyebrow. SctO2 
was monitored with an INVOS5100B cerebral oximeter 
(Somanetics, Troy, MI, USA), and the values from each 
side were averaged. For the continuous monitoring of 
SjO2, a Pre-Sep Oximetry Catheter (Edwards Lifesciences, 
Irvine, CA, USA) was connected to the Vigileo system and 
placed in the left jugular venous bulb. The catheter position 
was verified radiographically.
We recorded the SjO2, SctO2, MAP, heart rate (HR), CI, 
CVP, PaO2, PaCO2, hemoglobin concentration (Hb), BIS, 
and BT at the following points: 5 min before surgery (T0); 
5 min after inducing a 15 mmHg pneumoperitoneum (T1); 
5, 30, 60, 90, and 120 min after inducing the pneumoperi-
toneum in a 30° Trendelenburg position (T2, T3, T4, T5, 
and T6, respectively); and after desufflation in a supine 
position (T7).
Based on a pilot study, the sample size was calculated 
to detect a 9 % difference in the mean SjO2 value at T7 
using G power: 68 % (±9 %) for group P compared with 
77 % (±11 %) for group S. The power analysis indicated 
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that we needed a minimum sample size of 17 patients per 
group to detect an effect size of 0.89 using independent 
Student’s t tests with an α of 0.05 and a power of 0.80. 
Thus, we aimed to include 25 patients per each group to 
allow for a 30 % drop-out rate. The Shapiro–Wilk test was 
used to test the normality of the data. Demographic vari-
ables, duration of surgery and anesthesia, ephedrine and 
remifentanil doses, blood loss, urine output, and intrave-
nous fluid volume between groups were compared  using 
unpaired Student’s t tests. A two-way repeated-measures 
analysis of variance (ANOVA) with post hoc unpaired t 
test and Bonferroni correction was used to compare SjO2, 
SctO2, MAP, HR, CI, CVP, PaO2, PaCO2, Hb, BT, and 
BIS between the groups. A one-way repeated-measures 
ANOVA with Bonferroni post hoc tests was used to ana-
lyze these variables across time within the groups. All 
statistical tests were two-tailed. The correlation between 
SjO2 and SctO2 was evaluated by simple linear regression. 
Significance was determined at p < 0.05, and we used 
XLSTAT 2015 for Windows (Addinsoft, New York, USA) 
for all analyses. Data are expressed as mean (standard 
deviation).
Results
Of the 50 patients who were scheduled to enroll in the 
study, seven  (three in group S and four in group P) were 
excluded. One patient in group P was found to have a his-
tory of cerebral infarction after consenting to the study and 
six withdrew their consent before the operation. In group P, 
an additional two patients were excluded, one because nica-
rdipine was administered to treat intraoperative hyperten-
sion, and another because the FiO2 needed to be increased 
beyond the protocol limit to maintain the SaO2 >94 %. All 
of the measured values were normally distributed. There 
were no major complications on normal postoperative 
rounds in either group. As shown in Table 1, there were 
no significant differences in the demographic or anesthetic 
data between the groups.
Table 1  Demographic and 
anesthetic data
Data are presented as the mean (SD). There were no statistically significant differences between the two 
groups
Group S (n = 22) Group P (n = 19) p value
Age (years) 67 (4) 66 (4) 0.21
Weight (kg) 67 (8) 68 (6) 0.65
Height (cm) 165 (6) 166 (5) 0.22
Anesthetic time (min) 284 (39) 282 (37) 0.69
Operation time (min) 201 (40) 201 (32) 0.73
Fluid administered (ml) 1132 (362) 1103 (287) 0.78
Blood loss (ml) 94 (119) 108 (81) 0.65
Urine output (ml) 163 (124) 121 (82) 0.15
Ephedrine administered (mg) 47 (20) 40 (16) 0.11
Total dose of remifentanil administered (mg) 4.2 (1.2) 4.7 (0.8) 0.19
Fig. 1  The time courses of jugular venous oxygen saturations 
(SjO2) in groups that received sevoflurane (filled circle) and propo-
fol (opened circle). Values are expressed as mean (SD). Multi symbol 
p < 0.05 vs. group P
Fig. 2  The time courses for regional oxygen saturations (SctO2) in 
groups receiving sevoflurane (filled circle) and propofol (opened cir-
cle). Values are expressed as mean (SD). *p < 0.05 vs. T0
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Figure 1 shows that the SjO2 was significantly higher in 
group S at all measurement points (p < 0.05) with no sig-
nificant changes throughout the procedure when compared 
with T0. By contrast, Fig. 2 shows that there was no sig-
nificant difference in the SctO2 values between the groups 
at each point, but that SctO2 was significantly higher at T2 
than at T0 within each group.
Figure 3 shows that there were no differences across 
the measured time points between the groups in most of 
the key parameters that could affect SjO2 and SctO2. How-
ever, HR in group S was lower than that in group P at T0 
and T1. Compared with T0, the MAP was significantly 
higher at T1–T6 in group S, and at T1, T2, and T6 in group 
P. In both groups, CVP was significantly higher during 
pneumoperitoneum in the Trendelenburg position (T2–T6) 
compared with T0. In group P, Hb was significantly lower 
at T7 than at T0. Compared with T0, there were no differ-
ences within each group for PaO2, PaCO2, CI, Hb, BT, and 
BIS at each time point.
Figure 4 shows the linear regression analysis for SjO2 
and SctO2 during anesthesia, with evidence of only a weak 
relationship (β = 0.106; r2 = 0.065; p = 0.004).
Discussion
The present study is the first to compare cerebral oxygena-
tion by SjO2 between anesthetic regimens during RALP 
Fig. 3  Changes in a mean arterial pressure (MAP), b heart rate 
(HR), c cardiac index (CI), d central venous pressure (CVP), e naso-
pharyngeal temperature (BT), f Bispectral Index (BIS), g partial pres-
sures of arterial oxygen (PaO2), h partial pressures of carbon dioxide 
(PaCO2), and i hemoglobin concentration (Hb). Measurements were 
performed: 5 min before the commencement of surgery (T0); 5 min 
after a 15 mmHg pneumoperitoneum (T1); 5, 30, 60, 90 and 120 min 
after the Trendelenburg position (T2, T3, T4, T5, and T6, respec-
tively); and after exsufflation in the supine position (T7). Plus symbol 
p < 0.05 vs. T0 in group S. Hash symbol p < 0.05 vs. T0 in group P. 
Multi symbol p < 0.05 vs. group P
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and showed that sevoflurane had significantly higher lev-
els of SjO2 than propofol at all measurement points. We 
also observed no intergroup differences in MAP, CI, CVP, 
BT, BIS, PaO2, PaCO2, Hb at any time point and in the 
total ephedrine and remifentanil dose, even though HR was 
lower in group S at T0 and T1. The difference in HR may be 
explained by the higher doses of ephedrine administered in 
group P to treat hypotension during this period. Although not 
statistically significant, the PaO2 of group S was higher by 
about 15 mmHg at all measurement points, but this is likely 
too small to affect SjO2 physiologically and also from a lit-
erature review [14]. BT and BIS have been strongly related 
to cerebral metabolism [15, 16], but there were no signifi-
cant differences in these values between the groups suggest-
ing that there was no difference in CMRO2. Because we used 
sevoflurane at a mid-range concentration (above 1 MAC), we 
presumed that the cerebrovascular dilation effect was domi-
nant in group S and that the intergroup differences in SjO2 
were due to the differences in CBF.
Cerebral oxygen desaturation during surgery can predict 
early POCD and has been associated with delirium and pro-
longed hospitalization among the elderly [17, 18]. Current 
study might show that sevoflurane is better than propofol for 
RALP, but the result of our study does not directly indicate 
that sevoflurane is a superior choice for RALP. Cerebrovas-
cular dilation effect of sevoflurane also implies the cerebro-
vascular dysregulation, which can be amplified during RALP 
[19] and could result in hyperemia and cerebral edema. 
These aspects must be clarified if we are to demonstrate the 
superiority of sevoflurane over propofol in a clinical setting 
because they might occur prior to a decrease in SjO2 or cere-
bral perfusion pressure. Although we performed no cognitive 
tests, our study might suggest the appropriateness of sevoflu-
rane over propofol for patients with lower baseline values for 
SjO2 due to cerebrovascular stenosis during pneumoperito-
neum and a steep Trendelenburg position. A study compar-
ing sevoflurane and propofol anesthesia among patients with 
baseline SjO2 values <50 % showed no differences in post-
operative cognitive function [20], but the study did not show 
the SjO2 difference between the groups and did not control 
for BP, CI, or PaCO2, so we cannot assess the true relation-
ship between the anesthetics, SjO2, and postoperative cogni-
tive function. Several studies have shown the differences in 
cerebral oxygenation depending on the anesthetic used in a 
variety of clinical settings, but only a few have done so for 
pneumoperitoneum in the Trendelenburg position. One study 
tested whether SctO2 differed between propofol and sevoflu-
rane anesthesia during laparoscopic surgery in a 20° Tren-
delenburg position [21], and concluded that propofol was 
associated with significantly lower SctO2 than sevoflurane. 
In situations of raised ICP (e.g., brain tumors), research with 
volatile anesthetics have shown that they may maintain a 
significantly higher SjO2 compared with propofol [22]. Fur-
ther, in the supine position for normal surgery [23], in the 
sitting position for arthroscopy [13], and during one-lung 
ventilation for lung surgery [24], volatile anesthetics can 
maintain higher cerebral oxygenation than propofol. One 
pilot study has reported that, compared with sevoflurane, 
propofol increased cerebral SctO2 only when the stimulus 
of surgery was intense [25]. Although the authors specu-
lated that an increased propofol dose due to the stimulation 
caused the CMRO2 to decrease, the mechanism remains 
unclear because the concentrations of sevoflurane were not 
disclosed. Most of the studies discussed above, including the 
current study, indicate that volatile anesthetics cause higher 
cerebral oxygenation levels with no differences in neurologi-
cal complications or POCD when compared with propofol 
anesthesia. We also showed that SjO2 was well preserved 
in both groups (>50 %; Fig. 1). Although volatile anesthet-
ics and propofol presumably have the potential to decrease 
cerebral oxygenation during RALP, we showed that neither 
did so. Considering the lack of significant changes in SjO2 
compared with the baseline (T0), it is conceivable that pneu-
moperitoneum and a 30° Trendelenburg position may not 
affect cerebral oxygenation within 2 h. This may be because 
the predicted raise in ICP was within the physiological com-
pensation, such as cerebrospinal fluid (CSF) and blood mov-
ing into the spinal canal and extracranial vasculature not to 
suppress cerebral oxygenation, and also may be due to the 
effect of cerebrovascular autoregulation although that might 
be partly impaired in group S.
We also found only a weak relationship between SjO2 
and SctO2. There are several factors that could contribute to 
the inconsistency between the two values. First, SjO2 is an 
index of oxygenation for the entire brain, whereas SctO2 is 
an index of localized oxygenation in the frontal lobe [9–11, 
26]. Second, NIRS measures blood oxygenation in arteries, 
Fig. 4  Linear regression showing a weak relationship between 
regional oxygen saturation (SctO2) and jugular venous oxygen satura-
tion (SjO2). Data are for 328 measurement pairs from 41 patients
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veins, and capillaries combined; and is affected by extrac-
erebral blood flow, cerebrospinal fluid, and systemic blood 
pressure. By contrast, SjO2 measures only the intracerebral 
mixed venous saturation [27, 28]. Interestingly, in this study, 
SctO2 showed similar changes to BP across time, whereas 
SjO2 did not. Third, NIRS calculates SctO2 based on a fixed 
artery-to-vein ratio, regardless of changes induced by the 
Trendelenburg position and anesthetic agents [9, 28].
The present study has several limitations. First, we did 
not routinely perform cognitive tests. Thus, it remains 
unclear whether postoperative cognitive outcomes correlate 
with differences in cerebral oxygenation by different anes-
thetic agents; further research is needed. Second, we meas-
ured SjO2 unilaterally, and although no research has shown 
a clear difference between left and right SjO2, this may have 
affected the results. Third, we did not include patients with 
cerebrovascular disease and complications, so we cannot 
state how the SjO2 or SctO2 would have responded to RALP 
in patients with a cerebral pathology. Fourth, the values for 
ICP, CBF, and CMRO2 were not measured directly, which 
should be rectified in future research. Fifth, we limited the 
time spent with a pneumoperitoneum in the Trendelenburg 
position to 120 min, yet there have been reports of neuro-
logical complications due to brain edema when this proce-
dure exceeds 8 h [29]. Actually, cerebrovascular autoregula-
tion gradually changes with prolonged pneumoperitoneum 
in the Trendelenburg position; one study showed that it is 
decreased from 170 min [19]. Considering the inhibitory 
effect of volatile anesthetics on cerebrovascular autoregula-
tion, it may be worth comparing the effects of longer sur-
gery and steeper Trendelenburg positions in the future.
We conclude that  sevoflurane allows for a higher SjO2 
than propofol during RALP. We also conclude that SctO2 
does not accurately reflect SjO2 during this procedure. Ulti-
mately, further research is needed to determine the effect of 
anesthetics on hyperemia and cerebral edema during longer 
pneumoperitoneums and in steeper Trendelenburg positions, 
as well as on the potential correlation between postoperative 
cognitive outcomes and differences in cerebral oxygenation 
between anesthetic agents.
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